Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...

Demand for tamarind gum derivatives in the USA is entering a decade of steady expansion, rising from USD 18.5 million in 2025 to approximately USD 23.9 million by 2035, according to new market ...

Groups representing major companies, including Kraft Heinz and Coca-Cola, argue the law misleads consumers and violates the ...

The Nutraceutical Excipients Market was valued at USD 4.5 billion in 2024, reflecting strong expansion driven by the rising consumption ...

Glenmark Pharmaceuticals has recalled over eleven thousand bottles of its blood pressure drug Ziac after FDA testing found traces of the cholesterol medication ezetimibe. The Class III recall affects ...

You probably don't think twice when you reach for that bottle of extra virgin olive oil in your kitchen. Same goes for the ...

Phase 1 Maximal-use Phase 1 study evaluated pharmacokinetic (PK) profile following application of 3 tubes of Ameluz® over treatment area of 240 ...

Traces of another heart-related drug may be inside this product from a major pharmaceutical manufacturer, reveals an FDA report.

The FDA has cleared Neurosense to begin its pivotal Phase 3 clinical trial of PrimeC for the treatment of amyotrophic lateral ...

A wedding reception held on Sunday night in the Civil Lines area of Aligarh descended into chaos after two guests objected to ...

Longstanding regulatory and testing gaps have historically been filled by third-party groups with questionable methods.

Zantac and other ranitidine products were withdrawn nationwide in April 2020 over concerns an impurity could cause cancer.